Justin Kline, MD, is a hematologist/oncologist specializing in leukemia and lymphoma. His clinical interests include allogeneic stem cell transplantation (bone marrow or blood stem cells transplanted from a donor) in the treatment of these malignant diseases.

Dr. Kline's laboratory research focuses on overcoming barriers to immune resistance mechanisms in tumors. He develops models in mice to improve immune-mediated rejection of cancer that can be translated into clinical trials for patients with advanced malignancies.